Longevity
GHK-Cu
50 MG · Research Peptide
$39.00
A naturally occurring copper-binding tripeptide studied extensively in research related to skin biology and cellular signaling.
- 50 mg lyophilized powder per vial
- ≥ 99% purity, HPLC verified
- Cold-chain handled and batch tested
- For laboratory research use only
View GHK-CU batch Certificates of AnalysisGHK-Cu research guideRP-HPLC purity standards guideMass spectrometry testing guideStorage and refrigeration guideReconstitution guideGlossary of analytical terms
Research use only. Not for human consumption.
What is GHK-Cu (copper tripeptide-1)?
GHK-Cu is a copper(II) complex of the 3-amino-acid tripeptide glycyl-L-histidyl-L-lysine, commonly investigated in in-vitro skin and matrix research. It is not approved by the FDA as a therapeutic drug.
| Sequence | Gly-His-Lys complexed with copper(II) (GHK-Cu) |
|---|---|
| Length | 3 amino acids plus one Cu(II) ion |
| Molecular formula | C14H24CuN6O4 |
| Molecular weight | 403.9 g/mol (copper complex) |
| CAS number | 89030-95-5 |
| Purity specification | ≥ 99.0% by RP-HPLC |
| Research status | In-vitro and cosmetic-science research compound. No FDA-approved therapeutic indication. |
| Analytical methods | Reversed-phase HPLC (RP-HPLC) for purity and mass spectrometry (MS) for identity confirmation, reported per lot. |
| Available COA | Lot-specific Certificates of Analysis are published in the Vector E Lab COA library under the product name GHK-CU. View published certificates |
| Regulatory context | Supplied for Research Use Only (RUO) — in-vitro laboratory research and analytical testing by qualified personnel. Not for human or veterinary use, not for diagnostic procedures, and not a therapeutic product. |
| References |
Analytical specifications
| Purity (RP-HPLC) | ≥ 99.0% by reversed-phase HPLC |
|---|---|
| Fill quantity | 50 MG lyophilized powder per vial |
| Category | Longevity |
| Intended use | Research Use Only (RUO) — in-vitro laboratory research |
Batch Certificates of Analysis
| Batch number | Strength | Testing date | Certificate |
|---|---|---|---|
| SD-260728-1 | 50mg | 2026-08-10 | View COA (PDF) |
Frequently asked questions
- What is GHK-Cu (copper tripeptide-1)?
- GHK-Cu is a copper(II) complex of the 3-amino-acid tripeptide glycyl-L-histidyl-L-lysine, commonly investigated in in-vitro skin and matrix research. It is not approved by the FDA as a therapeutic drug. Sequence: Gly-His-Lys complexed with copper(II) (GHK-Cu). Molecular weight: 403.9 g/mol (copper complex). CAS number: 89030-95-5. Research status: In-vitro and cosmetic-science research compound. No FDA-approved therapeutic indication. Analytical methods: Reversed-phase HPLC (RP-HPLC) for purity and mass spectrometry (MS) for identity confirmation, reported per lot.
- What is the purity of GHK-Cu (Copper tripeptide-1)?
- GHK-Cu (Copper tripeptide-1) is released at ≥ 99.0% purity as determined by reversed-phase HPLC (RP-HPLC). Purity is reported per lot on the batch Certificate of Analysis.
- Is a Certificate of Analysis available for GHK-Cu?
- Yes. One published batch is listed on this page with batch number, strength, testing date and a downloadable COA PDF. Every certificate is also available in the Vector E Lab COA library.
- How is GHK-Cu supplied?
- Each vial contains 50 MG of lyophilized powder, supplied in the Longevity research category for in-vitro laboratory work.
- Can GHK-Cu be used in humans or animals?
- No. GHK-Cu (Copper tripeptide-1) is supplied strictly for Research Use Only (RUO) — in-vitro laboratory research and analytical testing by qualified laboratory personnel. It is not for human or veterinary use, diagnostic procedures, or therapeutic administration.
Related research peptides
